AARTIDRUGSPharmaceuticals
Aarti Drugs Ltd — PE Ratio & Valuation Analysis
₹319.75
-3.05%
Current P/E19.07xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E23.8x19.9% below avg
✅
40.0% Discount to Industry
AARTIDRUGS P/E 19.07x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹18.35 | ₹412 | 22.4x |
| 2024 | ₹18.56 | ₹460 | 24.8x |
| 2023 | ₹17.97 | ₹489 | 27.2x |
| 2022 | ₹22.14 | ₹460 | 20.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Aarti Drugs Ltd Valuation
Aarti Drugs Ltd (AARTIDRUGS) currently trades at 19.07x earnings. The Pharmaceuticals sector average PE is 31.77x. AARTIDRUGS is trading at a discount to peers — may indicate relative value. Historically, AARTIDRUGS has traded at an average PE of 23.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
12.69%
Dividend Yield
0.24%
More on Aarti Drugs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.